News

The Kathmandu Post23m
Navigating life with a rare disease
Additionally, the evolving national disease registries lack information about sarcoidosis, and limited awareness among ...
BioWorld2h
Abeona’s rare skin disease gene therapy approved by FDA
Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.
CNA Lifestyle2h
Should you still snuggle your pet when you're sick? Can your pet pass its sniffles to you?
Can your pet catch COVID-19 or the common cold from you? What can you expect the treatment to be if both you and your pet ...
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic ...
University of Toronto4h
Skin-based test could improve diagnosis of debilitating neurodegenerative disease
Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can ...
Medscape7h
FDA Approves First One-Time Topical Treatment for Recessive Dystrophic Epidermolysis Bullosa Wounds
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...
Crain's Cleveland Business8h
Cleveland company receives FDA approval for rare disease treatment
Cleveland-based Abeona Therapeutics Inc. (Nasdaq: ABEO) announced Tuesday, April 29, that it has received U.S. Food and Drug ...
Stocktwits on MSN8h
Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease
Shares of Abeona Therapeutics Inc. (ABEO) were in the spotlight on Tuesday afternoon after it announced that the U.S. Food ...
Precision Medicine Online9h
FDA Approves Abeona's Zevaskyn, EC Authorizes Krystal's Vyjuvek for Rare Skin Disease
Both gene therapies were approved as treatments for dystrophic epidermolysis bullosa, a rare and debilitating genetic skin condition.